Guru Ownership Trend
Guru Analysis for MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics (MLTX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 5 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $26.79 M.
Top institutional holders include Steven Cohen and Jefferies Group.
Institutional sentiment is currently Bullish. This is evidenced by a $19.88 M net inflow during the quarter.
Recent activity highlights Steven Cohen who dramatically increased their stake.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for MoonLake Immunotherapeutics (MLTX)
Major holders include Steven Cohen ($10.18 M), Jefferies Group ($6.59 M), Renaissance Technologies (RenTech) ($1.77 M). According to the latest reported data, 5 tracked investment managers collectively hold approximately 1.54 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $19.88 M, with 5 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in MLTX during the most recent reporting period.
Yes, 3 managers opened new positions in MLTX, and 2 increased their existing holdings. The total reported buy value was $19.88 M.